Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the noble rat model of sex hormone-induced prostatic dysplasia and carcinoma

Laboratory Investigation

Volumn 75, Issue 3, 1996, Pages 361-370

  Leav, Irwin ^a   Galluzzi, Cristina Magi ^b   Ziar, Jeffrey ^a   Stork, Philip J S ^c   Ho, Shuk Mei ^a   Loda, Massimo ^b  

^a TUFTS UNIVERSITY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; SEX HORMONE; TESTOSTERONE; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; CASTRATION; CONTROLLED STUDY; DYSPLASIA; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARCINOMA; CELL CYCLE PROTEINS; GONADAL STEROID HORMONES; IMMEDIATE-EARLY PROTEINS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASE; PROSTATIC DISEASES; PROSTATIC NEOPLASMS; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RATS, INBRED STRAINS;

EID: 0029840655     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bosland MC, Ford H, and Horton L (1995). Induction at high incidence of ductal prostate adenocarcinomas in NBI/CR and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17β or diethylstilbestrol. Carcinogenesis 16:1311-1317.
2. Bostwick DG and Brawer MK (1987). Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 59:788-794.
3. Clarke PR (1994). Switching off MAP-kinases. Curr Biol 4:647-650.
4. Drago JR (1984). The induction of Nb rat prostatic carcinomas. Anticancer Res 4:255-256.
5. Hill CS and Treisman R (1995). Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80: 199-211.
6. Ho S-M, Leav I, Damassa D, Kwan W-L, Merk FB, and Sato HSK (1989). Testosterone-mediated increase in 5α-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgen-independent prostate carcinoma of Noble rats. Cancer Res 48:609-614.
7. Ho S-M and Yu M (1993). Selective increase in type II estrogen-binding sites in dysplastic dorsolateral prostates of Noble rats. Cancer Res 53:528-532.
8. Hunter T (1995). Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signalling. Cell 225-236.
9. Karin M and Hunter T (1995). Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus. Curr Biol 5:747-757.
10. Kyriakis JM, Banerjee P, Nikolaki E, Dait, Rubie EA, Ahmed MF, Avruch J, and Woodjet JR (1994). The stress-activated protein kinase subfamily of c-JUN kinases. Nature 369:156-160.
11. Leav I, Ho S-M, Ofner P, Merk FB, Kwan PW-L, and Damassa D (1988). Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst 80:1045-1053.
12. Leav I, Kwan PW-I, Merk FB, Chang C, and Ho S-M (1992). Immunohistochemical and in situ hybridization studies of androgen receptor expression in a transplantable androgen-independent prostatic carcinoma line (AIT) of Noble rats. Lab Invest 67:788-795.
13. Leav I, Merk FB, Kwan PW-L, and Ho S-M (1989). Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats. Prostate 15:23-40.
14. MAPKK) in fibroblasts. J Cell Biol 122:1079-1088.
15. Liu Y, Gorospe M, Yang C, and Itolbrook N (1995). The role of mitogen activated protein kinase phosphatase during the cellular respond to genotoxic stress. J Biol Chem 270:8377-8380.
16. McNeal JE and Bostwick DG (1986). Intraductal dysplasia: A premalignant lesion of the prostate. Hum Pathol 17:64-71.
17. McNeal JE, Villars A, Redwine E, Freiha FS, and Stamey TA (1991). Microacinar carcinomas in the prostate: Its association with duct-acinar dysplasia. Hum Pathol 22:644-52.
18. Noble RL (1980). Development of androgen-stimulated transplants of Nb rat carcinoma of the dorsal prostate and their response to sex hormones and tamoxifen. Cancer Res 40: 3551-3554.
19. Noble RL (1982). Prostate carcinoma of the Nb rat in relation to hormones. Int Rev Exp Pathol 23:113-159.
20. Press-Misra A, Rim CS, Yao H, Roberson MS, and Stork PJS (1995). A novel mitogen-activated protein kinase phosphatase. J Biol Chem 270:14587-14596.
21. Prins GS, Woodhem C, Lepinske M, and Birch L (1993). Effects of neonatal estrogen exposure on prostatic secretory genes and their correlation with androgen receptor expression in the separate lobes of the adult rat. Endocrinology 132:2387-2398.
22. Scher HI, Sarkis A, Reuter V, Cohen D, et al, (1995). Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor α in the progression of prostatic neoplasms. Clin Cancer Res 1:545-550.
23. Steiner MS (1995). Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J Urol 153:1085-1096.
24. Steiner MS (1993). Role of peptide growth factors in the prostate: A review. Urology 42:99-110.
25. Sun H, Charles CH, Lau LF, and Tonks NK (1993). MKP-1 (3CH134) an immediate early gene product is a dual specification phosphatase that dephosphorylates MAP-kinase in vivo. Cell 75:487-493.
26. Sun H, Tonks NK, and Bar-Sagi D (1994). Inhibition of ras-induced DNA synthesis by expression of the phosphatase MKP-1. Science 266:285-288.
27. Yu M, Leav BA, Leav I, Merk FB, Wolfe HJ, and Ho S-M (1993). Early alterations in ras protooncogene mRNA expression in testosterone- and estradiol-17β-induced prostatic dysplasia of Noble rats. Lab Invest 68:33-44.